Cargando…
The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
PURPOSE: Concerns have been raised that modern intensity modulated radiotherapy (IMRT) may be associated with increased second primary cancer risks (SPC) compared to previous three-dimensional conformal radiation techniques (3DCRT), due to increased low dose volumes and more out-of-field ionizing do...
Autores principales: | Jahreiß, Marie-Christina, Aben, Katja K. H., Hoogeman, Mischa S., Dirkx, Maarten L. P., de Vries, Kim C., Incrocci, Luca, Heemsbergen, Wilma D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691574/ https://www.ncbi.nlm.nih.gov/pubmed/33282746 http://dx.doi.org/10.3389/fonc.2020.605119 |
Ejemplares similares
-
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
por: Jahreiß, Marie-Christina, et al.
Publicado: (2021) -
Association between incidental dose outside the prostate and tumor control after modern image-guided radiotherapy
por: Witte, Marnix, et al.
Publicado: (2021) -
Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020) -
Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020) -
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis
por: Sinzabakira, F., et al.
Publicado: (2023)